Is it safe?
Can DGX take a bad year?
Quest Diagnostics carries $5.26B of net debt at 2.41× EBITDA: a load its earnings can carry.
$5.26B
Net debt · as at Q1 2026 · under two and a half years of EBITDA, comfortable
- Net debt / EBITDA
- 2.41×
Net debt / EBITDA · 2.97× a year ago · the load is coming down
- Altman Z-score
- 3.35
Altman Z-score · safe zone, above 3
- Interest cover
- 5.96×
Interest cover · operating profit covers the interest bill several times over
Details›
- Total debtQ1 2026
- $5.66B
- Cash and short-term investments
- $393M
- Net debt
- $5.26B
- EBITDA, trailing twelve months
- $2.19B
- Operating profit, trailing twelve months
- $1.61B
- Debt / equity
- 0.77×
- Total debt / EBITDA
- 2.59×
- Annualised volatilitytwo years of daily moves
- 23%
- Worst drawdown on file
- −37%
- Below its 52-week high
- 0.00%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Diagnostics & Research
Ranks #24 of 29 by Smart Score